OSCR

Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention.

Overview

Authors: Yue Li1,2, Chi Qin1,2, Chenxu Miao1,2, Ronghao Mu2,3, Penghua Zhang1,2, Bohao Zhang1,2, Xin Zhao1,2, Xiaoan Zhang1,2
  1. Department of Radiology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
  2. Department of Clinical Research and Translational Medicine, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
  3. Department of Child Developmental Behavior, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Journal: Frontiers in immunology, volume 17, article 1837728
Dates: received 24 March 2026; accepted 31 May 2026; published online 12 June 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3389/fimmu.2026.1837728 · PMID 42367795 · PMCID PMC13303037 · OpenAlex W7164587810
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: mouse (organism), other condition (population), stroke (population), cellular / molecular (subfield)
Methods: Statistics, Connectivity, Graphs, Spectral & time-frequency
Keywords: 3-BrPA, bioinformatics, glycolysis, HIBD, HK2
MeSH: Glycolysis*, Hexokinase*, Hypoxia-Ischemia, Brain*, Neuroinflammatory Diseases*, Animals, Disease Models, Animal, Male, Metabolic Reprogramming, Mice, Mice, Inbred C57BL, Protein Interaction Maps, Pyruvates, Up-Regulation (* major topic)
Topic: Neonatal and fetal brain pathology (Pediatrics, Perinatology and Child Health, Medicine), according to OpenAlex
Citations: not cited yet (Europe PMC); 59 references in the paper

Abstract

Background: Hypoxic-ischemic brain damage (HIBD) involves profound metabolic reprogramming, where aberrant glycolysis links to neuronal injury. This study aimed to identify and characterize glycolysis-related hub genes in HIBD.

Methods: Glycolysis-related differentially expressed genes (DEGs) were screened from the HIBD dataset GSE144456 by combining differential expression analysis, weighted gene co-expression network analysis (WGCNA), and a glycolysis gene set. Hub genes were further identified via enrichment and protein-protein interaction (PPI) network analyses and validated in an independent dataset (GSE23317) and our internal RNA-seq. The key hub gene was confirmed in a mouse HIBD model using RT-qPCR and Western blot. To perturb Hexokinase 2 (Hk2), 3-bromopyruvate (3-BrPA, 1 mg/kg) was administered 1 hour post-HIBD, and its effects were evaluated by MRI, molecular assays, and behavioral tests.

Results: Bioinformatics analysis identified Hk2 as a key hub gene that was consistently upregulated in HIBD. In vivo experiments demonstrated that both HK2 protein and mRNA levels were significantly elevated 24 hours after HIBD (P < 0.001). Double immunofluorescence staining further revealed that the upregulated HK2 was predominantly localized to Iba1+ microglia. Early administration of 3-BrPA reduced acute cerebral infarction volume (P < 0.001), improved neurological function scores (P < 0.001), and concurrently​ downregulated HK2 protein levels (P < 0.05). 3-BrPA treatment also significantly reduced lactate accumulation in the injured brain tissue (P < 0.001). ​It also​ suppressed the mRNA expression of pro-inflammatory cytokines (Tnf, Il1b, and Il6; all P < 0.001) and modulated the protein levels of inflammatory markers (iNOS, ARG1; P < 0.05 and P < 0.01, respectively). Moreover, this single early intervention significantly mitigated long-term brain tissue loss and improved motor coordination and exploratory behavior at 30 days post-injury (P < 0.05).

Conclusion: Hk2 is highlighted as a critical node associated with both glycolytic reprogramming and neuroinflammation in HIBD, with upregulation primarily in microglia. Early perturbation of glycolysis with 3-BrPA is associated with multifaceted benefits. Our findings link the Hk2-glycolysis axis to neuroinflammation, offering a rationale for exploring metabolic interventions in HIBD.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Data links

  • ncbi.nlm.nih.gov/geo — NCBI; found in the text, “Bioinformatics data sources and pretreatment”

Data availability statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 8 authors, 5 keywords, 13 MeSH terms, 1 funder, 59 references.

Cite

This paper

Li, Y., Qin, C., Miao, C., Mu, R., Zhang, P., Zhang, B., Zhao, X., & Zhang, X. (2026). Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention. Frontiers in immunology, 17, 1837728. https://doi.org/10.3389/fimmu.2026.1837728

BibTeX

@article{li2026hexokinase,
author = {Li, Yue and Qin, Chi and Miao, Chenxu and Mu, Ronghao and Zhang, Penghua and Zhang, Bohao and Zhao, Xin and Zhang, Xiaoan},
title = {{Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention}},
journal = {Frontiers in immunology},
year = {2026},
month = jun,
volume = {17},
pages = {1837728},
publisher = {Frontiers Media SA},
issn = {1664-3224},
doi = {10.3389/fimmu.2026.1837728},
url = {https://doi.org/10.3389/fimmu.2026.1837728},
pmid = {42367795},
pmcid = {PMC13303037}
}

RIS

TY - JOUR
AU - Li, Yue
AU - Qin, Chi
AU - Miao, Chenxu
AU - Mu, Ronghao
AU - Zhang, Penghua
AU - Zhang, Bohao
AU - Zhao, Xin
AU - Zhang, Xiaoan
TI - Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention
T2 - Frontiers in immunology
J2 - Front Immunol
PY - 2026
DA - 2026/06/12
VL - 17
SP - 1837728
SN - 1664-3224
PB - Frontiers Media SA
DO - 10.3389/fimmu.2026.1837728
UR - https://doi.org/10.3389/fimmu.2026.1837728
LA - en
ER -

CSL-JSON

{
"id": "10.3389/fimmu.2026.1837728",
"type": "article-journal",
"title": "Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention",
"container-title": "Frontiers in immunology",
"author": [
{
"family": "Li",
"given": "Yue"
},
{
"family": "Qin",
"given": "Chi"
},
{
"family": "Miao",
"given": "Chenxu"
},
{
"family": "Mu",
"given": "Ronghao"
},
{
"family": "Zhang",
"given": "Penghua"
},
{
"family": "Zhang",
"given": "Bohao"
},
{
"family": "Zhao",
"given": "Xin"
},
{
"family": "Zhang",
"given": "Xiaoan"
}
],
"container-title-short": "Front Immunol",
"volume": "17",
"page": "1837728",
"DOI": "10.3389/fimmu.2026.1837728",
"PMID": "42367795",
"PMCID": "PMC13303037",
"ISSN": "1664-3224",
"publisher": "Frontiers Media SA",
"URL": "https://doi.org/10.3389/fimmu.2026.1837728",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
12
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s13024-026-00956-y [code]
In vivo profiling of astrocyte secretome reveals brain-region specific regulatory networks in a mouse model of amyloid pathology.
Journal: Molecular neurodegeneration
In common: mouse, cellular / molecular, 3 references
[2] doi:10.2147/ijn.s621038
Protein Lactylation in Central Nervous System Diseases: Molecular Mechanisms and Targeted Therapeutic Strategies.
Journal: International journal of nanomedicine
In common: cellular / molecular, 2 references
[3] doi:10.3389/fped.2026.1891438
Identification and clinical validation of F3 as a peripheral blood biomarker for neonatal hypoxic-ischemic encephalopathy using dataset-specific bioinformatics analysis.
Journal: Frontiers in pediatrics
In common: other condition, 2 references
[4] doi:10.3390/pathophysiology33030043
A Differentiated SH-SY5Y Model of Hypoxic-Ischaemic Injury Reveals Dynamic Transcriptomic Responses During Reoxygenation.
Journal: Pathophysiology : the official journal of the International Society for Pathophysiology
In common: stroke, other condition, cellular / molecular, 1 reference
[5] doi:10.1016/j.redox.2026.104210
Vespakinin-M delineates an AMPK/mTOR-arginine-TCA cycle axis to act as an immunometabolic switch in post-stroke microglia.
Journal: Redox biology
In common: stroke, mouse, cellular / molecular, 1 reference
[6] doi:10.1002/ctm2.70683 [code]
Niacin promotes motor function recovery after spinal cord injury via Hcar2-dependent microglia immunometabolic regulation.
Journal: Clinical and translational medicine
In common: other condition, mouse, cellular / molecular, 1 reference
[7] doi:10.1186/s12964-026-02871-7
Hematopoietic cell kinase regulates microglial/macrophage activation to drive neuroinflammation after traumatic brain injury.
Journal: Cell communication and signaling : CCS
In common: mouse, cellular / molecular, 1 reference
[8] doi:10.1186/s40035-026-00567-z
Transaldolase 1 contributes to pentose phosphate pathway disruption and synaptic dysfunction in Alzheimer's disease.
Journal: Translational neurodegeneration
In common: mouse, cellular / molecular, 1 reference
[9] doi:10.1186/s12974-026-03838-8 [code]
Acarbose modulates microglial Pkm2 acetylation to reshape immunometabolism and preserve retinal neurons after ischemia-reperfusion.
Journal: Journal of neuroinflammation
In common: mouse, cellular / molecular, 1 reference
[10] doi:10.1016/j.bbih.2026.101253
Inflammatory reprogramming of immature oligodendrocytes perturbs myelination and neurodevelopment in a dual-hit model of preterm brain injury.
Journal: Brain, behavior, & immunity - health
In common: other condition, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.